# META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

> clinical trial · VERIFIED · 2026-07-08

Status: NOT_YET_RECRUITING · Sponsor: Institute of Hematology & Blood Diseases Hospital, China · Condition: Autoimmune Hemolytic Anemia (AIHA)

- Company: Institute of Hematology & Blood Diseases Hospital, China
- Sector: Autoimmune Hemolytic Anemia (AIHA)
- Primary source: https://clinicaltrials.gov/study/NCT07689604

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.